Faculty profile

Parvez Vora

Back to faculty
Lecturer (Adjunct)SurgeryMcMaster University

Research

Research areas, by share of publications

Research areas are derived from OpenAlex topics of their publications.

78 publications.

01

Generation of Allogeneic CAR‐T Circumvents Functional Deficits in Patient‐Derived Autologous Product for Glioblastoma

Salim SK, Shaikh MV, Wei J, Maich WT, Anand A, Tang OY, Subapanditha MK, Alizada Z, Suk Y, Singh M

International Journal of Cancer2026
02

Intratumoral Delivery of Chimeric Antigen Receptor T Cells Targeting CD133 Effectively Treats Brain Metastases.

Kieliszek AM, Mobilio D, Upreti D, Bloemberg D, Escudero L, Kwiecien JM, Alizada Z, Zhai K, Ang P, Chafe SC

Clinical Cancer Research202426 citations
03

EXTH-51. ENHANCING GLIOBLASTOMA TREATMENT: ALLOGENEIC CAR-T CELLS OVERCOMES FUNCTIONAL DEFICITS OF PATIENT-DERIVED AUTOLOGOUS PRODUCTS

Shaikh MV, Salim SK, Maich WT, Ananad A, Wei J, Subapanditha MK, Suk Y, Singh M, Tabunshchyk Z, Chen K

Neuro-Oncology20241 citations
04

Abstract 5241: Generation of allogeneic CAR-T circumvents functional deficits in patient-derived autologous product for glioblastoma

Shaikh MV, Salim SK, Wei J, Maich WT, Anand AA, Tang OY, Subapanditha MK, Suk Y, Singh M, Alizada Z

Cancer Research20241 citations
05

AUTOLOGOUS PATIENT-DERIVED CAR-TS SHOW FUNCTIONAL DEFICITS AGAINST HUMAN GLIOBLASTOMA

Salim SK, Shaikh V, Maich WT, Anand A, Brakel B, Wei J, Subapanditha MK, Alizada Z, Suk Y, Singh M

NOA20231 citations
06

SYST-33 GENERATION OF ALLOGENEIC CAR-T CIRCUMVENTS FUNCTIONAL DEFICITS IN PATIENT-DERIVED AUTOLOGOUS PRODUCT FOR GLIOBLASTOMA

Shaikh MV, Salim SK, Maich WT, Anand A, Wei J, Subapanditha MK, Suk Y, Singh M, Tabunshchyk Z, Chen K

NOA2023Open Access
07

CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment

Seyfrid M, Maich WT, Shaikh VM, Tatari N, Upreti D, Piyasena D, Subapanditha M, Savage N, McKenna D, Mikolajewicz N

Journal for ImmunoTherapy of Cancer202277 citationsOpen Access
08

Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma

Qazi MA, Salim SK, Brown KR, Mikolajewicz N, Savage N, Han H, Subapanditha MK, Bakhshinyan D, Nixon A, Vora P

Cell reports202232 citationsSenior author
09

Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma

Qazi MA, Salim SK, Brown KR, Mickolajewicz N, Savage N, Han H, Subapanditha MK, Bakhshinyan D, Nixon A, Vora P

bioRxiv (Cold Spring Harbor Laboratory)20221 citationsSenior authorOpen Access
10

Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence

Bakhshinyan D, Adile AA, Liu J, Gwynne WD, Suk Y, Custers S, Burns I, Singh M, McFarlane N, Subapanditha MK

Science Advances202123 citations
Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for
Subject: Prospective PhD student: Glioma Diagnosis and Treatment Dear Professor Vora, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Generation of Allogeneic CAR‐T Circumvents Functional Deficits in Patient‐Derived Autologous Product for Glioblastoma" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]
Open in email
Something wrong or missing on this profile? Suggest a correction